Gab2 deficiency suppresses high-fat diet-induced obesity by reducing adipose tissue inflammation and increasing brown

Xinhui Wang1, Yinan Zhao1, Dekun Zhou1

  • 1School of Pharmaceutical Sciences, State Key Laboratory of Cellular Stress Biology, Xiamen University, 361005, Xiamen, Fujian, China.

Cell Death & Disease
|February 27, 2021
PubMed

Insights

Deleting Gab2, a signaling protein, combats diet-induced obesity by reducing weight gain and improving glucose tolerance. Gab2 deficiency also enhances thermogenesis and reduces inflammation, suggesting it as a therapeutic target.

Area of Science:

  • Metabolic research
  • Cell signaling
  • Obesity research

Background:

  • Obesity stems from energy imbalance, regulated by complex signaling pathways.
  • Signaling scaffolding protein Gab2's role in obesity is not fully understood.

Purpose of the Study:

  • To investigate the effect of Gab2 on diet-induced obesity.
  • To elucidate the regulatory mechanisms of Gab2 in obesity and adipocyte function.

Main Methods:

  • Gab2 knockout (KO) and wild-type (WT) mice were fed standard or high-fat diets for 12 weeks.
  • In vitro studies used primary/immortalized brown preadipocytes to assess adipocyte differentiation and gene expression.
  • Key signaling pathways, including PI3K-Akt-FoxO1, were analyzed.

Main Results:

  • Gab2 deficiency attenuated high-fat diet-induced weight gain and improved glucose tolerance.
  • Gab2 deletion reduced white adipose tissue and systemic inflammation.
  • Gab2 deficiency upregulated thermogenic genes (e.g., Ucp1) in brown adipose tissue and differentiated adipocytes.

Conclusions:

  • Gab2 deletion suppresses diet-induced obesity through multiple pathways, including enhanced thermogenesis and reduced inflammation.
  • Gab2 plays a significant role in regulating adipocyte function and energy balance.
  • Gab2 emerges as a potential therapeutic target for obesity and related metabolic complications.

Related Concept Videos